Ipatasertib + Pertuzumab +Trastuzumab in Advanced HER2+ PI3KCA-mutant Breast Cancer Patients

Clinical trial NCT04253561 · COMPLETED

Trial details

NCT number: NCT04253561
Sponsor: SOLTI Breast Cancer Research Group
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Breast Cancer

Start date: 2020-02-25
Primary completion: 2021-12-05
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.